In addition, lean NAFLD is associated with lower levels of proinflammatory cytokines (e.g., interleukin 6 and tumor necrosis factor alpha), which are known as a risk factors for cardiovascular disease, metabolic syndrome, and insulin resistance. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.